Abstract:Background Currently, some studies have demonstrated that miR-34a could serve as a suppressor of several cancers including hepatocellular carcinoma (HCC). Previously, we discovered that miR-34a was downregulated in HCC and involved in the tumorigenesis and progression of HCC; however, the mechanism remains unclear. The purpose of this study was to estimate the expression of miR-34a in HCC by applying the microarray profiles and analyzing the predicted targets of miR-34a and their related biological pathways of HCC. Methods Gene expression omnibus (GEO) datasets were conducted to identify the difference of miR-34a expression between HCC and corresponding normal tissues and to explore its relationship with HCC clinicopathologic features. The natural language processing (NLP), gene ontology (GO), pathway and network analyses were performed to analyze the genes associated with the carcinogenesis and progression of HCC and the targets of miR-34a predicted in silico. In addition, the integrative analysis was performed to explore the targets of miR-34a which were also relevant to HCC. Results The analysis of GEO datasets demonstrated that miR-34a was downregulated in HCC tissues, and no heterogeneity was observed (Std. Mean Difference(SMD) = 0.63, 95% confidence intervals(95%CI):[0.38, 0.88], P < 0.00001; P heterogeneity = 0.08 I 2 = 41%). However, no association was found between the expression value of miR-34a and any clinicopathologic characteristics. In the NLP analysis of HCC, we obtained 25 significant HCC-associated signaling pathways. Besides, we explored 1000 miR-34a-related genes and 5 significant signaling pathways in which CCND1 and Bcl-2 served as necessary hub genes. In the integrative analysis, we found 61 hub genes and 5 significant pathways, including cell cycle, cytokine-cytokine receptor interaction, notching pathway, p53 pathway and focal adhesion, which proposed the relevant functions of miR-34a in HCC. Conclusion Our results may lead researchers to understand the molecular mechanism of miR-34a in the diagnosis, prognosis and therapy of HCC. Therefore, the interaction between miR-34a and its targets may promise better prediction and treatment for HCC. And the experiments in vivo and vitro will be conducted by our group to identify the specific mechanism of miR-34a in the progress and deterioration of HCC.

Application of miRNA in the prognosis of patients with hepatocellular carcinoma

Research Progress of MicoRNA in Molecular Targeting Treatment of Hepatocellular Carcinoma

Application of Microrna and Mrna Expression Profiling on Prognostic Biomarker Discovery for Hepatocellular Carcinoma

Role of miRNA in pathogenesis, diagnosis, and prognosis in hepatocellular carcinoma

Identification of Prognostic miRNAs Targeting EZH2 in Hepatocellular Carcinoma Using The Cancer Genome Atlas Database

MicroRNAs in Hepatocellular Carcinoma: Regulation, Function, and Clinical Implications

Elucidating hepatocellular carcinoma progression: a novel prognostic miRNA-mRNA network and signature analysis

Function and Clinical Potential of Micrornas in Hepatocellular Carcinoma

Clinicopathological Role of Mir-30A-5p in Hepatocellular Carcinoma Tissues and Prediction of Its Function with Bioinformatics Analysis

Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma

Progression of the Functions of Microrna on HCC Metastasis and Prognosis

Advances in research on the role and mechanism of microRNAs in hepatic carcinogenesis

Microarray Expression Profiling of microRNAs Reveals Potential Biomarkers for Hepatocellular Carcinoma.

The Mrna-Mirna-lncrna Regulatory Network and Factors Associated with Prognosis Prediction of Hepatocellular Carcinoma

Diagnostic and Prognostic Implications of Micrornas in Human Hepatocellular Carcinoma

The roles and clinical applications of microRNAs in hepatocellular carcinoma

Role of Mirna in Pathogenesis, Diagnosis, and Prognosis in Hepatocellular Carcinoma.

Identification of a Novel Metastasis-Related miRNAs-Based Signature for Predicting the Prognosis of Hepatocellular Carcinoma

Potential Microrna Panel For The Diagnosis And Prediction Of Overall Survival Of Hepatocellular Carcinoma With Hepatitis B Virus Infection

Use of miRNA Sequencing to Reveal Hub miRNAs and the Effect of miR-582-3p/SMAD2 in the Progression of Hepatocellular Carcinoma

A miR-212-3p/SLC6A1 Regulatory Sub-Network for the Prognosis of Hepatocellular Carcinoma